CDMO's & Cell and Gene Therapy
Russell Perry
Location: Virtual – Microsoft Teams
Wednesday, August 13th, 2025
Time: 12 PM to 1 PM
ABSTRACT:
Russell will be talking about CDMO's (Contract Development and Manufacturing Organization) and their role in aiding pharmaceutical companies in the drug discovery/manufacturing pipeline. He will share the work that the Cell & Gene Therapy department does on the bench scale that aids contracted clients in their groundbreaking research in this novel biopharmaceutical field. He will discuss analytical techniques such as ELISAs (enzyme-linked immunosorbent assays), HPLC (high performance liquid chromatography), CE (capillary electrophoresis) and others that are crucial for stability and release testing of drug substances and products. He will also answer questions about drug pipelines, FDA regulation, and how cell and gene therapies are drawing attention in the pharmaceutical industry.
Russell Perry
Russell Perry received his BS and MS from Tennessee Tech University in 2023 and 2024 respectively, both in Chemical Engineering. This piqued his interest in analytical biochemistry which led to his acceptance of a job offer in the greater Madison, Wisconsin area at Thermo Fisher Scientific (formerly PPD). He works in the Cell and Gene Therapy (CGT) department in routine and non-routine stability testing on various CGT drug compounds.
- Log in to post comments